Total Number of Enoxaparin Doses for ACS
For NSTEMI, STEMI, and unstable angina, enoxaparin is typically administered every 12 hours for the duration of hospitalization or until revascularization, with most patients receiving between 2-8 doses depending on timing of intervention. 1
Dosing Regimen by ACS Type
NSTEMI and Unstable Angina (Initial Medical Therapy)
- Standard dosing: 1 mg/kg subcutaneous every 12 hours 1
- Duration: Continue until PCI/revascularization or hospital discharge
- Typical course: Most patients receive 3-6 doses before proceeding to catheterization 2
- Research data shows a median of 3 doses (mean 0.51 mg/kg) administered before PCI in NSTEMI patients, with the final dose given approximately 10.8 hours pre-procedure 2
STEMI with Fibrinolytic Therapy
The dosing differs significantly by age:
For patients <75 years:
- Initial 30 mg IV bolus
- Followed by 1 mg/kg subcutaneous every 12 hours (maximum 100 mg for first 2 doses)
- Duration: Up to 8 days 1, 3
- Total doses: Typically 16 subcutaneous doses plus initial bolus over 8 days
For patients ≥75 years:
- No IV bolus
- 0.75 mg/kg subcutaneous every 12 hours (maximum 75 mg for first 2 doses)
- Duration: Up to 8 days 1
- Total doses: Up to 16 doses over 8 days
Renal Impairment Adjustments
Critical caveat: For CrCl <30 mL/min at any age:
- Reduce to 1 mg/kg subcutaneous every 24 hours 1
- This halves the total number of doses (approximately 8 doses over 8 days for STEMI)
Timing Considerations for PCI
When transitioning from medical therapy to PCI, additional dosing depends on timing of last dose 1:
- Last dose 8-12 hours prior OR only 1 dose given: Administer 0.3 mg IV bolus
- Last dose within 8 hours: No additional enoxaparin needed
- No prior anticoagulation: 0.5-0.75 mg/kg IV bolus
Evidence Quality and Practical Application
The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines provide the most authoritative dosing framework 1. The ExTRACT-TIMI 25 trial established the 8-day maximum duration for STEMI patients, demonstrating superior efficacy versus UFH with acceptable bleeding risk when using age-adjusted dosing 3.
Common pitfall: Continuing enoxaparin post-PCI without clear indication. Research shows that routine anticoagulation after uncomplicated PCI does not reduce MACCE but increases minor bleeding 4. Discontinue enoxaparin after successful PCI unless there is a specific ongoing indication.
Practical Algorithm:
- NSTEMI/UA: Start 1 mg/kg q12h → Continue until PCI (typically 2-6 doses) → Stop after successful intervention
- STEMI with lysis: Age-adjusted dosing → Continue up to 8 days (16 doses) or until revascularization
- Adjust for renal function: CrCl <30 = switch to daily dosing (halves total doses)